Literature DB >> 24675946

Cancer. Cholesterol and cancer, in the balance.

Sandrine Silvente-Poirot1, Marc Poirot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24675946     DOI： 10.1126/science.1252787

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  85 in total

1.  Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.

Authors:  F Cerrato; M E Fernández-Suárez; R Alonso; M Alonso; C Vázquez; O Pastor; P Mata; M A Lasunción; D Gómez-Coronado
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

Review 2.  Metabolomic profiling of hormone-dependent cancers: a bird's eye view.

Authors:  Stacy M Lloyd; James Arnold; Arun Sreekumar
Journal:  Trends Endocrinol Metab       Date:  2015-08-01       Impact factor: 12.015

Review 3.  Estrogens regulate life and death in mitochondria.

Authors:  Carolyn M Klinge
Journal:  J Bioenerg Biomembr       Date:  2017-08       Impact factor: 2.945

Review 4.  Omega-3 fatty acids, membrane remodeling and cancer prevention.

Authors:  Natividad R Fuentes; Eunjoo Kim; Yang-Yi Fan; Robert S Chapkin
Journal:  Mol Aspects Med       Date:  2018-04-12

5.  Activation of Lyn tyrosine kinase through decreased membrane cholesterol levels during a change in its membrane distribution upon cell detachment.

Authors:  Takao Morinaga; Kohei Abe; Yuji Nakayama; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

Review 6.  The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.

Authors:  Erik R Nelson
Journal:  Mol Cell Endocrinol       Date:  2017-09-15       Impact factor: 4.102

Review 7.  27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.

Authors:  Sisi He; Erik R Nelson
Journal:  Maturitas       Date:  2017-07-31       Impact factor: 4.342

8.  The Valuable Role of Measuring Serum Lipid Profile in Cancer Progression.

Authors:  Farahnaz Ghahremanfard; Majid Mirmohammadkhani; Banafsheh Shahnazari; Golnaz Gholami; Jamileh Mehdizadeh
Journal:  Oman Med J       Date:  2015-09

9.  The cross-talk of LDL-cholesterol with cell motility: insights from the Niemann Pick Type C1 mutation and altered integrin trafficking.

Authors:  Monira Hoque; Carles Rentero; James R Conway; Rachael Z Murray; Paul Timpson; Carlos Enrich; Thomas Grewal
Journal:  Cell Adh Migr       Date:  2015-09-14       Impact factor: 3.405

10.  EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesis.

Authors:  Xiaowen Guan; Houliang Deng; Un Lam Choi; Zhengfeng Li; Yiqi Yang; Jianming Zeng; Yunze Liu; Xuanjun Zhang; Gang Li
Journal:  Oncogene       Date:  2020-10-02       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.